Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 14 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 14 | 360 aa | 336 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.3682 | 0.2147 |
Echinococcus multilocularis | plexin a4 | 0.0211 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0104 | 0.3682 | 0.2822 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0152 | 0.6525 | 0.5681 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0152 | 0.6525 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0178 | 0.8075 | 0.7608 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0041 | 0 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0152 | 0.6525 | 0.5681 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0152 | 0.6525 | 0.5681 |
Onchocerca volvulus | 0.0178 | 0.8075 | 1 | |
Schistosoma mansoni | plexin | 0.0178 | 0.8075 | 1 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0152 | 0.6525 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0152 | 0.6525 | 0.5681 |
Schistosoma mansoni | plexin | 0.0104 | 0.3682 | 0.2822 |
Loa Loa (eye worm) | plexin A | 0.0211 | 1 | 1 |
Brugia malayi | Plexin repeat family protein | 0.0178 | 0.8075 | 0.7608 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0041 | 0 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0152 | 0.6525 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0152 | 0.6525 | 0.5681 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0152 | 0.6525 | 0.5681 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0152 | 0.6525 | 0.5681 |
Brugia malayi | P38 map kinase family protein 2 | 0.0152 | 0.6525 | 0.5681 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0152 | 0.6525 | 0.5 |
Echinococcus granulosus | plexin a4 | 0.0211 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1 uM | Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA | ChEMBL. | 24900264 |
IC50 (binding) | = 1.7 uM | Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay | ChEMBL. | 24900264 |
IC50 (binding) | = 3.1 uM | Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA | ChEMBL. | 24900264 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.